96 related articles for article (PubMed ID: 17597205)
1. Analysis of apoptosis regulatory genes expression in the bone marrow (BM) of adult de novo myelodysplastic syndromes (MDS).
Economopoulou C; Pappa V; Kontsioti F; Papageorgiou S; Kapsimali V; Papasteriadi C; Economopoulou P; Papageorgiou E; Dervenoulas J; Economopoulos T
Leuk Res; 2008 Jan; 32(1):61-9. PubMed ID: 17597205
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS).
Economopoulou C; Pappa V; Papageorgiou S; Kontsioti F; Economopoulou P; Charitidou E; Girkas K; Kapsimali V; Papasteriadi C; Tsirigotis P; Papageorgiou E; Dervenoulas J; Economopoulos T
Ann Hematol; 2010 Apr; 89(4):349-58. PubMed ID: 19813013
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
[TBL] [Abstract][Full Text] [Related]
5. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
9. What does apoptosis have to do with clinical features in myelodysplastic syndrome?
Ramos F; Fuertes-Núñez M; Suárez-Vilela D; Fernández-López A
Haematologica; 2002 Apr; 87(4):381-91. PubMed ID: 11940482
[TBL] [Abstract][Full Text] [Related]
10. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
Kurata M; Hasegawa M; Nakagawa Y; Abe S; Yamamoto K; Suzuki K; Kitagawa M
Exp Mol Pathol; 2006 Dec; 81(3):249-54. PubMed ID: 16566920
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders.
Jiang Y; Mishima H; Sakai S; Liu YK; Ohyabu Y; Uemura T
J Orthop Res; 2008 Jul; 26(7):910-7. PubMed ID: 18302252
[TBL] [Abstract][Full Text] [Related]
12. High incidence of apoptosis in peripheral blood of myelodysplastic syndrome patients determined by Papanicolaou-stained preparations.
Emura I
Lab Hematol; 2003; 9(1):42-6. PubMed ID: 12661827
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
[TBL] [Abstract][Full Text] [Related]
14. Accelerated cellular senescence in myelodysplastic syndrome.
Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
[TBL] [Abstract][Full Text] [Related]
16. [Expression of PDCD5 in multiple myeloma and its relation with BCL-2].
Jiang TB; Li X; Zhou J; Zhou Y; Yuan H; Xiang H; Yang GP; Lü HW; Xing XW; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):814-20. PubMed ID: 18812660
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.
Lepelley P; Soenen V; Preudhomme C; Merlat A; Cosson A; Fenaux P
Leukemia; 1995 Apr; 9(4):726-30. PubMed ID: 7723410
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in the myelodysplastic syndromes.
Westwood NB; Mufti GJ
Curr Hematol Rep; 2003 May; 2(3):186-92. PubMed ID: 12901339
[TBL] [Abstract][Full Text] [Related]
19. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
[TBL] [Abstract][Full Text] [Related]
20. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
